JIXING
Dead / Abandoned — Abandoned — failure to respond (as of 16 Dec 2022)
What this means for you
This application is over — abandoned 01 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97410225
- Mark type
- Design + words
- Filed
- 13 May 2022
- Abandoned
- 01 Dec 2022
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Human medicine, Pharmaceutical formulation, Chemical pharmaceutical formulation, Medical ointment, Bronchiectasis formulation, Injection, Tablet, Tincture, Water-based, Ointment, Drugs for the treatment of infectious diseases, Pharmaceutical formulation for the treatment of hypercholesterolemia, Pharmaceutical formulation for the treatment of hyperlipidemia, Pharmaceutical formulation for the treatment of asthma, Cholesterol lowering agents, Blood pressure medication, Antidiabetic drugs, Antidiabetic formulation, Antiarrhythmic formulation, Cardiovascular pharmaceutical formulation, Medical formulation for eye or intraocular surgery, Pharmaceutical products for ophthalmic use, Ophthalmic formulation, Eye formulation, Cardiovascular drugs for medical purposes, Inhaled medical formulation used for the treatment of pulmonary hypertension
- Class 042 — Scientific and technological services: Scientific research and development; Drug development services; Drug research services, Development of pharmaceutical formulation and medicines, Biomedical research services, Medical research services, Chemical Research; Biotechnology research, Drug testing; Software as a Service (SaaS)
Owner
- Ji Xing Pharmaceuticals (Shanghai) Co., Ltd., Shanghai, CN
Prosecution history
- 16 Dec 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Dec 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 16 Dec 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2022 — NON-FINAL ACTION E-MAILED
- 31 May 2022 — NON-FINAL ACTION WRITTEN
- 30 May 2022 — ASSIGNED TO EXAMINER
- 19 May 2022 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 18 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 May 2022 — NEW APPLICATION ENTERED